Results 121 to 130 of about 84,964 (303)
EPI Update, July 20, 2007 [PDF]
, 2007 Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...
core
Endoscopic small bowel therapies for type 2 diabetes
Nutrition in Clinical Practice, EarlyView.Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel +4 more
wiley +1 more source
Botulinum Toxin and Its Contribution to the Treatment of Masseteric Hypertrophy
Česká Stomatologie a Praktické Zubní Lékařství, 2005 With discovery and use of botulinum toxin masseteric hypertrophy has become treatable in a minimal invasive way. The authors discuss the masseteric hypertrophy as such as well as they describe a technique of clinical application of botulinum toxin in its
R. Jurkovič, P. Macák
doaj
Botulinum toxin in management of back pain
Quality in SportIntroduction The botulinum toxin is a widely used therapeutic agent. It is used for aesthetic reasons in treatment of glabellar wrinkles. Therapeutic indications include cervical dystonia, hyperhidrosis or migrenes.
Blanka Łuczak +9 more
doaj +1 more source
A Comprehensive Review of the Genetic Etiology and Management of Orofacial Clefts
Pediatric Discovery, EarlyView.ABSTRACT Cleft lip (CL) and cleft palate (CP), collectively referred to as orofacial clefts (OFCs), are among the most common birth defects and can have significant effects on speech, nutrition, and physical and psychosocial development. Manifestation, classification, and treatment plans of OFCs are diverse and not standardized.
Emily Kim +3 more
wiley +1 more source
Botulinum toxin use in patients with neurological disorders: A U.S.‐based claims database analysis
PM&R, EarlyView.Abstract Background and Objective Real‐world evidence describing long‐term persistency with botulinum toxin (BoNT) therapy is limited. We assessed treatment patterns and persistency with BoNT in clinical practice over 2 years. Design Retrospective, longitudinal, claims database analysis. Setting Medical claims data from the Merative MarketScan database
David M. Simpson +4 more
wiley +1 more source
Responsive Materials, EarlyView.An oxygen‐responsive living bioreactor was engineered via interspecies protoplast fusion, converting oxygen from an inhibitory stress into a programmable signal for sustained indole‐3‐propionic acid (IPA) production. This genetically encoded bioreactor enables robust aerobic operation and therapeutic efficacy of deoxynivalenol detoxification in vivo ...
Ning Ma +8 more
wiley +1 more source
POTILASOPAS BOTULIINITOKSIINIHOITOON TULEVALLE LAPSELLE [PDF]
, 2011 Opinnäytetyön tarkoituksena oli tehdä potilasopas botuliinitoksiinihoitoon tulevalle lapselle. Potilasopasta käytetään valmistaessa lasta tulevaan toimenpiteeseen sekä hoitoa antavassa yksikössä että kotona.
Koskinen, Saija, Virnes, Kirsi
core